Share on StockTwits

Pharma Bio Serv (NASDAQ:PBSV) posted its quarterly earnings results on Friday. The company reported $0.01 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.05 by $0.04, AnalystRatingsNetwork reports.

PBSV has been the subject of a number of recent research reports. Analysts at Zacks reiterated an “outperform” rating on shares of Pharma Bio Serv in a research note on Tuesday. They now have a $3.00 price target on the stock.

Pharma Bio Serv (NASDAQ:PBSV) opened at 1.45 on Friday. Pharma Bio Serv has a one year low of $1.20 and a one year high of $2.50. The stock has a 50-day moving average of $1.7 and a 200-day moving average of $1.87. The company has a market cap of $33.4 million and a price-to-earnings ratio of 7.41.

Pharma-Bio Serv, Inc(NASDAQ:PBSV) is a compliance and technology transfer services consulting firm with a laboratory testing facility, servicing the Puerto Rico, United States and Europe markets.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.